One-year clinical trial data for the next-generation, investigational, Sphere-360TM single-shot PFA catheter show impressive safety, perf ...

Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

Medtronic , a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption ...

According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected ...

Abbott Laboratories ABT has recorded a 15% rise in its share price year to date. Despite the company reporting a solid ...

Olympus announced today that it appointed Bob White, former Medtronic EVP, as its new CEO, effective June 1, 2025.

Medtronic has signed an agreement for the distribution of Dragonfly Endoscopy’s pancreaticobiliary system in the US.

TOKYO, Apr 25, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people's ...

In a head-to-head study, three continuous glucose monitoring systems show different measurements in the same person, which may affect therapeutic decision-making.

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the companies' partnership.